Articles By This Author

History shows Iowa’s 2025 season could be noteworthy, or maybe even better – Hawk Fanatic

History shows Iowa’s 2025 season could be noteworthy, or maybe even better  Hawk Fanatic Source link

SHOP

Kids Character Shoes from $4 on Walmart.com | Stitch, Bluey, Winnie The Pooh, & More!

Hip2Save may earn a small commission at no extra cost to you via trusted partners and affiliate links in this post. Prices and availability are

TECH

Judge says FTC investigation into Media Matters ‘should alarm all Americans’

A federal judge has granted a preliminary injunction blocking the Federal Trade Commission’s investigation into left-leaning advocacy group Media Matters. Back in 2023, Media Matters

LOCAL NEWS

What to do on Day 11 of the 2025 Iowa state Fair

mom the Mhm. Okay, husbands, how would you like it if your wife called you like this? Yeah. Get in suffer. I’m gonna feed it

Press Release: Dwight Evans Co-Leads Introduction of BENES 2.0 Act to Aid Medicare Enrollment for Seniors – Quiver Quantitative

Press Release: Dwight Evans Co-Leads Introduction of BENES 2.0 Act to Aid Medicare Enrollment for Seniors  Quiver Quantitative Source link

BUSINESS

Loeffler and Hinson tour Bloomsbury Farm, highlight federal benefits for Iowa businesses – KGAN

Loeffler and Hinson tour Bloomsbury Farm, highlight federal benefits for Iowa businesses  KGAN Source link

ENTERTAINMENT

Phil Rosenthal, State Fair shows and jorts: 9 can’t-miss Des Moines events this week – The Des Moines Register

Phil Rosenthal, State Fair shows and jorts: 9 can’t-miss Des Moines events this week  The Des Moines Register Source link

LIFESTYLE

Garnaas banrkuptcy the biggest, but not the last in real estate market – Business Record

Garnaas banrkuptcy the biggest, but not the last in real estate market  Business Record Source link

REAL ESTATE

Sellers’ market: D.M.-area home sales up 22 percent – The Des Moines Register

Sellers’ market: D.M.-area home sales up 22 percent  The Des Moines Register Source link

RFK Jr. Is Supporting mRNA Research—Just Not for Vaccines

One of the targeted recipients, Tiba Biotech, had a $750,000 contract with BARDA that was slated to end October 30. The company was developing an